StockNews.com initiated coverage on shares of Cumberland Pharmaceuticals (NASDAQ:CPIX – Free Report) in a research report sent to investors on Thursday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock.
Cumberland Pharmaceuticals Stock Up 1.6 %
Shares of NASDAQ CPIX opened at $1.28 on Thursday. Cumberland Pharmaceuticals has a 1 year low of $1.20 and a 1 year high of $2.36. The company has a market capitalization of $18.16 million, a P/E ratio of -2.17 and a beta of 0.20. The company has a 50 day simple moving average of $1.31 and a 200-day simple moving average of $1.46. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.44 and a quick ratio of 1.26.
About Cumberland Pharmaceuticals
Further Reading
- Five stocks we like better than Cumberland Pharmaceuticals
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- Insider Selling is not a Signal to Start Selling Gartner Stock
- Buy P&G Now, Before It Sets A New All-Time High
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- How to Most Effectively Use the MarketBeat Earnings Screener
- Is Lucid Group Nearing the Bottom? What Investors Should Know
Receive News & Ratings for Cumberland Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cumberland Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.